Literature DB >> 15264319

Bone cement X-ray contrast media: a clinically relevant method of measuring their efficacy.

F Kjellson1, T Almén, K E Tanner, I D McCarthy, L Lidgren.   

Abstract

It is important to compare different contrast media used in bone cement according to their ability to attenuate X-rays and thereby produce image contrast between bone cement and its surroundings in clinical applications. The radiopacity of bone cement is often evaluated by making radiographs of cement in air at an X-ray tube voltage of 40 kV. We have developed a method for ranking contrast media in bone cement simulating the clinical situation, by (1) choosing the same X-ray tube voltage as used in clinical work, and (2) using a water phantom to imitate the effects of the patients' soft tissue on the X-ray photons. In clinical work it is desirable to have low radiation dose, but high image contrast. The voltage chosen is a compromise, because both dose and image contrast decrease with higher voltage. Three contrast media (ZrO(2), BaSO(4), and Iodixanol) have been compared for degree of "image contrast." Comparing 10 wt % contrast media samples at an X-ray tube voltage of 40 kV, ZrO(2) produced higher image contrast than the other media. However, at 80 kV, using a water phantom, the results were reversed, ZrO(2) produced lower image contrast than both BaSO(4) and Iodixanol. We conclude that evaluations of contrast media should be made with voltages and phantoms imitating the clinical application. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264319     DOI: 10.1002/jbm.b.30060

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  5 in total

1.  Doped calcium-aluminium-phosphate cements for biomedical applications.

Authors:  V Medri; M Mazzocchi; A Bellosi
Journal:  J Mater Sci Mater Med       Date:  2010-12-17       Impact factor: 3.896

2.  Nano iron oxide-hydroxyapatite composite ceramics with enhanced radiopacity.

Authors:  M Ajeesh; B F Francis; John Annie; P R Harikrishna Varma
Journal:  J Mater Sci Mater Med       Date:  2010-02-27       Impact factor: 3.896

3.  In vitro and in vivo biological responses to a novel radiopacifying agent for bone cement.

Authors:  J S Wang; J Diaz; A Sabokbar; N Athanasou; F Kjellson; K E Tanner; I D McCarthy; L Lidgren
Journal:  J R Soc Interface       Date:  2005-03-22       Impact factor: 4.118

4.  A daptomycin-xylitol-loaded polymethylmethacrylate bone cement: how much xylitol should be used?

Authors:  Ali Salehi; Ashley Cox Parker; Gladius Lewis; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

5.  Effect of iodixanol particle size on the mechanical properties of a PMMA based bone cement.

Authors:  Fred Kjellson; Saba Abdulghani; K E Tanner; Ian D McCarthy; Lars Lidgren
Journal:  J Mater Sci Mater Med       Date:  2007-01-30       Impact factor: 4.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.